It’s estimated that a staggering 75% of all emerging human infectious diseases originate from animals and birds. These zoonosis, as they’re known, are what compel us to innovate – to succeed in the fight against the likes of avian flu, brucellosis and Q-fever. They’re one of the driving forces behind our vision: ‘Together, beyond animal health’.
We work with welfare and social programs around the world to bring this vision to life – anywhere our products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where we supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
We’re truly global, based in 42 countries and working across more than 110. We have 13 R&D centres, 21 production sites and more than 3.500 employees worldwide.
We’ve grown both organically, driven by product development and sales, and through acquisitions. Now we’re one of the leading animal health players. An independent company owned by its people – something that’s distinct in our industry.
Our clear, company-wide vision unites all our businesses and products – working as one has been critical to our success. And we’re results-driven.
We give the entrepreneurs who join us the freedom to work their way to achieve our shared goals.